Antipodean Advisors LLC Cardlytics, Inc. Transaction History
Antipodean Advisors LLC
- $18.2 Million
- Q3 2023
A detailed history of Antipodean Advisors LLC transactions in Cardlytics, Inc. stock. As of the latest transaction made, Antipodean Advisors LLC holds 20,000 shares of CDLX stock, worth $27,799. This represents 1.81% of its overall portfolio holdings.
Number of Shares
20,000
Previous 35,000
42.86%
Holding current value
$27,799
Previous $221,000
49.32%
% of portfolio
1.81%
Previous 1.7%
Shares
8 transactions
Others Institutions Holding CDLX
# of Institutions
101Shares Held
25.4MCall Options Held
1.66MPut Options Held
910K-
Cliff Sosin Cas Investment Partners, LLC | New York, Ny5.2MShares$7.23 Million0.56% of portfolio
-
Black Rock Inc. New York, NY3.15MShares$4.38 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.4MShares$3.34 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.63MShares$2.27 Million0.0% of portfolio
-
Kps Global Asset Management Uk LTD London, X01.22MShares$1.69 Million0.38% of portfolio
About Cardlytics, Inc.
- Ticker CDLX
- Exchange NASDAQ
- Sector Communication Services
- Industry Advertising Agencies
- Shares Outstandng 32,893,800
- Market Cap $45.7M
- Description
- Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and var...